142 related articles for article (PubMed ID: 26034081)
1. Characterization of CM572, a Selective Irreversible Partial Agonist of the Sigma-2 Receptor with Antitumor Activity.
Nicholson H; Comeau A; Mesangeau C; McCurdy CR; Bowen WD
J Pharmacol Exp Ther; 2015 Aug; 354(2):203-12. PubMed ID: 26034081
[TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of MAM03055A: A novel bivalent sigma-2 receptor/TMEM97 ligand with cytotoxic activity.
Liu CZ; Mottinelli M; Nicholson HE; McVeigh BM; Wong NK; McCurdy CR; Bowen WD
Eur J Pharmacol; 2021 Sep; 906():174263. PubMed ID: 34144027
[TBL] [Abstract][Full Text] [Related]
3. Sigma-2 Receptors Play a Role in Cellular Metabolism: Stimulation of Glycolytic Hallmarks by CM764 in Human SK-N-SH Neuroblastoma.
Nicholson H; Mesangeau C; McCurdy CR; Bowen WD
J Pharmacol Exp Ther; 2016 Feb; 356(2):232-43. PubMed ID: 26574517
[TBL] [Abstract][Full Text] [Related]
4. Divergent Cytotoxic and Metabolically Stimulative Functions of Sigma-2 Receptors: Structure-Activity Relationships of 6-Acetyl-3-(4-(4-(4-fluorophenyl)piperazin-1-yl)butyl)benzo[
Nicholson HE; Alsharif WF; Comeau AB; Mesangeau C; Intagliata S; Mottinelli M; McCurdy CR; Bowen WD
J Pharmacol Exp Ther; 2019 Feb; 368(2):272-281. PubMed ID: 30530624
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective targets through which 6-acetyl-3-(4-(4-(4-fluorophenyl)piperazin-1-yl)butyl)benzo[d]oxazol-2(3H)-one (SN79), a sigma receptor ligand, mitigates the effects of methamphetamine in vitro.
Kaushal N; Robson MJ; Rosen A; McCurdy CR; Matsumoto RR
Eur J Pharmacol; 2014 Feb; 724():193-203. PubMed ID: 24380829
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and pharmacological evaluation of 6-acetyl-3-(4-(4-(4-fluorophenyl)piperazin-1-yl)butyl)benzo[d]oxazol-2(3H)-one (SN79), a cocaine antagonist, in rodents.
Kaushal N; Robson MJ; Vinnakota H; Narayanan S; Avery BA; McCurdy CR; Matsumoto RR
AAPS J; 2011 Sep; 13(3):336-46. PubMed ID: 21494909
[TBL] [Abstract][Full Text] [Related]
7. Sigma-2 receptor agonists activate a novel apoptotic pathway and potentiate antineoplastic drugs in breast tumor cell lines.
Crawford KW; Bowen WD
Cancer Res; 2002 Jan; 62(1):313-22. PubMed ID: 11782394
[TBL] [Abstract][Full Text] [Related]
8. CB-64D and CB-184: ligands with high sigma 2 receptor affinity and subtype selectivity.
Bowen WD; Bertha CM; Vilner BJ; Rice KC
Eur J Pharmacol; 1995 May; 278(3):257-60. PubMed ID: 7589164
[TBL] [Abstract][Full Text] [Related]
9. Selective sigma-2 ligands preferentially bind to pancreatic adenocarcinomas: applications in diagnostic imaging and therapy.
Kashiwagi H; McDunn JE; Simon PO; Goedegebuure PS; Xu J; Jones L; Chang K; Johnston F; Trinkaus K; Hotchkiss RS; Mach RH; Hawkins WG
Mol Cancer; 2007 Jul; 6():48. PubMed ID: 17631687
[TBL] [Abstract][Full Text] [Related]
10. The σ
Gasparre G; Abate C; Carlucci R; Berardi F; Cassano G
Pharmacol Rep; 2017 Jun; 69(3):542-545. PubMed ID: 28364693
[TBL] [Abstract][Full Text] [Related]
11. F281, synthetic agonist of the sigma-2 receptor, induces Ca2+ efflux from the endoplasmic reticulum and mitochondria in SK-N-SH cells.
Cassano G; Gasparre G; Niso M; Contino M; Scalera V; Colabufo NA
Cell Calcium; 2009 Apr; 45(4):340-5. PubMed ID: 19187959
[TBL] [Abstract][Full Text] [Related]
12. Substituted benzo[d]oxazol-2(3H)-one derivatives with preference for the sigma1 binding site.
Zampieri D; Grazia Mamolo M; Laurini E; Zanette C; Florio C; Collina S; Rossi D; Azzolina O; Vio L
Eur J Med Chem; 2009 Jan; 44(1):124-30. PubMed ID: 18440098
[TBL] [Abstract][Full Text] [Related]
13. Modulation of cellular calcium by sigma-2 receptors: release from intracellular stores in human SK-N-SH neuroblastoma cells.
Vilner BJ; Bowen WD
J Pharmacol Exp Ther; 2000 Mar; 292(3):900-11. PubMed ID: 10688603
[TBL] [Abstract][Full Text] [Related]
14. Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines.
Vilner BJ; John CS; Bowen WD
Cancer Res; 1995 Jan; 55(2):408-13. PubMed ID: 7812973
[TBL] [Abstract][Full Text] [Related]
15. The sigma-2 receptor agonist PB28 inhibits calcium release from the endoplasmic reticulum of SK-N-SH neuroblastoma cells.
Cassano G; Gasparre G; Contino M; Niso M; Berardi F; Perrone R; Colabufo NA
Cell Calcium; 2006 Jul; 40(1):23-8. PubMed ID: 16687172
[TBL] [Abstract][Full Text] [Related]
16. Structure-Activity Relationships within a Series of σ
Franchini S; Sorbi C; Battisti UM; Tait A; Bencheva LI; Cichero E; Fossa P; Cilia A; Prezzavento O; Ronsisvalle S; Aricò G; Benassi L; Vaschieri C; Azzoni P; Magnoni C; Brasili L
ChemMedChem; 2017 Nov; 12(22):1893-1905. PubMed ID: 28940806
[TBL] [Abstract][Full Text] [Related]
17. New sigma and 5-HT1A receptor ligands: omega-(tetralin-1-yl)-n-alkylamine derivatives.
Berardi F; Colabufo NA; Giudice G; Perrone R; Tortorella V; Govoni S; Lucchi L
J Med Chem; 1996 Jan; 39(1):176-82. PubMed ID: 8568804
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, in vitro and in vivo characterization of new benzoxazole and benzothiazole-based sigma receptor ligands.
Romeo G; Prezzavento O; Intagliata S; Pittalà V; Modica MN; Marrazzo A; Turnaturi R; Parenti C; Chiechio S; Arena E; Campisi A; Sposito G; Salerno L
Eur J Med Chem; 2019 Jul; 174():226-235. PubMed ID: 31042618
[TBL] [Abstract][Full Text] [Related]
19. Role of sigma-1 receptor C-terminal segment in inositol 1,4,5-trisphosphate receptor activation: constitutive enhancement of calcium signaling in MCF-7 tumor cells.
Wu Z; Bowen WD
J Biol Chem; 2008 Oct; 283(42):28198-215. PubMed ID: 18539593
[TBL] [Abstract][Full Text] [Related]
20. In vitro characterization of SLV308 (7-[4-methyl-1-piperazinyl]-2(3H)-benzoxazolone, monohydrochloride): a novel partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist.
Glennon JC; Van Scharrenburg G; Ronken E; Hesselink MB; Reinders JH; Van Der Neut M; Long SK; Feenstra RW; McCreary AC
Synapse; 2006 Dec; 60(8):599-608. PubMed ID: 17001660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
